148 Characterizing cancer’s dark matter, short-lived proteins, and defective ribosomal products, presented by cancer and contained in the DPV-001 cancer vaccine
Ryan Meng(Providence Portland Medical Center), Bernard A. Fox(Oregon Health & Science University), William L. Redmond(Providence St. Vincent Medical Center), Noriko Iwamoto(Shimadzu (Japan)), Alexa K. Dowdell(Providence Portland Medical Center), Walter J. Urba(Providence Portland Medical Center), Yuriko Minegishi(National Institutes of Health), Koji Ueda(RIKEN Center for Integrative Medical Sciences), Tarsem Moudgil(Providence Portland Medical Center), R. Bryan Bell(Takara (United States)), Rachel E. Sanborn(Providence Portland Medical Center), Tanisha Christie(Providence Portland Medical Center), Venkatesh Rajamanickam(Cancer Institute (WIA)), Carlo Bifulco(Providence Health & Services), Rom S. Leidner(Providence Portland Medical Center), Traci Hilton(UbiVac (United States)), Yoshinobu Koguchi(Providence Portland Medical Center), Brian Piening(Providence College), Takashi Shimada(Keio University), Shawn M. Jensen(Providence Portland Medical Center), Hong‐Ming Hu(Viva Biotech (China))
Cited by 1
Related Papers
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
|Journal of Clinical Investigation|2004|1.4k
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
|Science|2019|1.1k
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
Longitudinal multi-omics of host–microbe dynamics in prediabetes
|Nature|2019|620